Nascent Biotech, Inc. (NBIO)

Nascent Biotech Statistics

Total Valuation

NBIO has a market cap or net worth of $16.69 million. The enterprise value is $16.19 million.

Market Cap	16.69M
Enterprise Value	16.19M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

NBIO has 169.73 million shares outstanding. The number of shares has increased by 39.95% in one year.

Shares Outstanding	169.73M
Shares Change (YoY)	+39.95%
Shares Change (QoQ)	+12.64%
Owned by Insiders (%)	40.00%
Owned by Institutions (%)	0.63%
Float	93.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	549.59
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 4.12.

Current Ratio	1.05
Quick Ratio	n/a
Debt / Equity	4.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.66

Financial Efficiency

Return on equity (ROE) is -6,892.89% and return on invested capital (ROIC) is -1,450.55%.

Return on Equity (ROE)	-6,892.89%
Return on Assets (ROA)	-326.40%
Return on Capital (ROIC)	-1,450.55%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-152,271
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +99.60% in the last 52 weeks. The beta is -3.20, so NBIO's price volatility has been lower than the market average.

Beta (1Y)	-3.20
52-Week Price Change	+99.60%
50-Day Moving Average	0.12
200-Day Moving Average	0.13
Relative Strength Index (RSI)	42.40
Average Volume (30 Days)	48,544

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-2
Operating Income	-2.25M
Pretax Income	-2.09M
Net Income	-2.09M
EBITDA	-2.25M
EBIT	-2.87M
Earnings Per Share (EPS)	-$0.01

Balance Sheet

The company has $623,854 in cash and $125,000 in debt, giving a net cash position of $498,854 or $0.00 per share.

Cash & Cash Equivalents	623,854
Total Debt	125,000
Net Cash	498,854
Net Cash Per Share	$0.00
Equity / Book Value	30,367
Book Value Per Share	0.00
Working Capital	30,366

Cash Flow

Operating Cash Flow	-1.22M
Capital Expenditures	n/a
Free Cash Flow	-1.22M
FCF Per Share	-$0.01

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.95%
Shareholder Yield	-39.95%
Earnings Yield	-12.54%
FCF Yield	-7.32%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2